{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:36:34Z","timestamp":1776479794215,"version":"3.51.2"},"reference-count":147,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,9,21]]},"DOI":"10.1080\/14656566.2024.2409941","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T12:21:07Z","timestamp":1727958067000},"page":"1923-1941","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The pharmacological management of alcohol-related cirrhosis: what\u2019s new?"],"prefix":"10.1080","volume":"25","author":[{"given":"Nipun","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin P","family":"Vinod","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, University of Louisville School of Medicine, Louisville, KY, USA"},{"name":"Department of Transplant Hepatology, Jewish Hospital and Trager Transplant Center, Louisville, Kentucky, USA"},{"name":"Department of Research, Veteran Affairs Medical Center, Sioux Falls, SD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16461"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.469"},{"key":"e_1_3_4_5_1","unstructured":"Grand rounds: alcoholic hepatitis - PubMed [internet]. [cited 2024 Jun 6]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29753761\/"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7683"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412278"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105703"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1990.01410130019002"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123857"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1981.tb04890.x"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1901974116"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3417"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11004-3"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002275"},{"key":"e_1_3_4_16_1","unstructured":"List-of-accepted-LB-Abstracts-EASL-Congress-2024-1.pdf [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/www.easlcongress.eu\/wp-content\/uploads\/2024\/04\/List-of-accepted-LB-Abstracts-EASL-Congress-2024-1.pdf"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235557"},{"key":"e_1_3_4_18_1","volume-title":"Trends in Alcoholic Liver Disease Research","author":"Ichiro S","year":"2012","unstructured":"Ichiro S, Mari K, Hideshi Y, et al. Gender Difference in Alcoholic Liver Disease. In: Ichiro S, editor. Trends in Alcoholic Liver Disease Research Rijeka: IntechOpen; 2012. p. Ch. 2."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2023.10.002"},{"issue":"4","key":"e_1_3_4_20_1","first-page":"257","article-title":"Influence of alcohol and gender on immune response","volume":"26","author":"Kovacs EJ","year":"2002","unstructured":"Kovacs EJ, Messingham KAN. Influence of alcohol and gender on immune response. Alcohol Res Health. 2002;26(4):257\u2013263.","journal-title":"Alcohol Res Health"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6270.1140"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.35946\/arcr.v40.2.10"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07610-y"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13214"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030564"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.039"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15028"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061965"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48267-2"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30249"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.02.033"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2023.2230115"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47085-y"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140134"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081374"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00476-8"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1668374"},{"key":"e_1_3_4_38_1","unstructured":"Selonsertib and Prednisolone in Alcoholic Hepatitis (AH) - Clinical Trials Registry - ICH GCP [Internet]. [cited 2024 May 11]. Available from: https:\/\/ichgcp.net\/clinical-trials-registry\/NCT02854631"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.09.001"},{"issue":"2","key":"e_1_3_4_40_1","first-page":"207","article-title":"Alcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications","volume":"38","author":"Simon L","year":"2017","unstructured":"Simon L, Jolley SE, Molina PE. Alcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications. Alcohol Res Curr Rev. 2017;38(2):207\u2013217.","journal-title":"Alcohol Res Curr Rev"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343879"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13425"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607185009005590"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.8627"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S55842"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.007"},{"key":"e_1_3_4_47_1","unstructured":"Sarcopenia and Frailty in Cirrhosis: Assessment and Management - PubMed [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37001955\/"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.12.003"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i42.11914"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1118531"},{"key":"e_1_3_4_51_1","unstructured":"Kudo H Yata Y Takahara T et al. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/scholar.google.com\/scholar_lookup?title=Telmisartan+attenuates+progression+of+steatohepatitis+in+mice"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80285-7"},{"key":"e_1_3_4_53_1","unstructured":"Cirrhosis-associated immune dysfunction | Nature Reviews Gastroenterology & Hepatology. [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/www.nature.com\/articles\/s41575-021-00520-7"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2022.01.001"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.01.011"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4949148"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01939-9"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1975.tb19146.x"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32101"},{"issue":"6","key":"e_1_3_4_60_1","first-page":"510","article-title":"Consumption of \u201ccountry liquor\u201d and its relation to alcoholic liver disease in Mumbai","volume":"46","author":"Narawane NM","year":"1998","unstructured":"Narawane NM, Bhatia S, Abraham P, et al. Consumption of \u201ccountry liquor\u201d and its relation to alcoholic liver disease in Mumbai. J Assoc Physicians India. 1998 Jun;46(6):510\u2013513.","journal-title":"J Assoc Physicians India"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.043"},{"key":"e_1_3_4_62_1","unstructured":"Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. [Internet]. [cited 2024 Apr 26]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26256464\/"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31042"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12117"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.12.019"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12939"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1336-z"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16179"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15207"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000306"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.4902"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-018-0859-4"},{"key":"e_1_3_4_73_1","unstructured":"Long-term outcomes of stool transplant in alcohol-associated hepatitis\u2014analysis of clinical outcomes relapse gut microbiota and comparisons with standard care. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35814513\/"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000458"},{"key":"e_1_3_4_75_1","unstructured":"Mitchell M. Novel therapies in moderately severe acute alcoholic hepatitis. Report No.: NCT01922895. [Internet]. clinicaltrials.gov. 2022 Feb [cited 2024 Jan 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01922895"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117451"},{"issue":"8","key":"e_1_3_4_77_1","article-title":"The beneficial effects of Lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"V V","year":"2023","unstructured":"V V, F W, K M, et al. The beneficial effects of Lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis. Am J Gastroenterol. 2023 Aug 1 [cited 2024 Jun 21];118(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37040544\/","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082551"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07505-8"},{"key":"e_1_3_4_80_1","unstructured":"Virginia Commonwealth University. A multicenter randomized double-blind placebo-controlled dosing safety and efficacy study of IMM 124-E (hyperimmune bovine colostrum) for patients with severe alcoholic hepatitis. [Internet]. Report No.: NCT01968382. clinicaltrials.gov. 2020 Jan [cited 2024 Jan 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01968382"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1162"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1742-x"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.031"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32478"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-3-311"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511.pub3"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202203260802"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.039"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-9-685"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.011"},{"key":"e_1_3_4_91_1","unstructured":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. [Internet]. [cited 2024 Jun 7] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34166722\/"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112338"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.01.042"},{"key":"e_1_3_4_94_1","unstructured":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19445945\/"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05719-2"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.08.057"},{"key":"e_1_3_4_97_1","unstructured":"Gilead Sciences. A phase 2 double-blind randomized study evaluating the safety tolerability and efficacy of GS-4997 in combination with prednisolone versus prednisolone alone in subjects with severe alcoholic hepatitis (AH). Report No.: NCT02854631. [Internet]. clinicaltrials.gov. 2019 Feb [cited 2024 Jan 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02854631"},{"key":"e_1_3_4_98_1","unstructured":"Alcohol disrupts human liver stem\/progenitor cell proliferation and differentiation. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27547491\/"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.03.044"},{"key":"e_1_3_4_100_1","unstructured":"Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23855297\/"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.154"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22317"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100139"},{"key":"e_1_3_4_104_1","unstructured":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials. [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32775975\/"},{"key":"e_1_3_4_105_1","unstructured":"Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11113088\/"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-015-9585-9"},{"key":"e_1_3_4_107_1","unstructured":"Co-stimulation of LPAR1 and S1PR1\/3 increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29898789\/"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.05.027"},{"key":"e_1_3_4_109_1","unstructured":"A decade of progress in liver regenerative medicine. [Internet]. [cited 2024 Jun 7: Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29274550\/"},{"key":"e_1_3_4_110_1","unstructured":"Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages. [Internet]. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29895168\/"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.03.027"},{"key":"e_1_3_4_112_1","unstructured":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. [Internet]. J Hepatol. [cited 2024 Jun 7]. Available from: https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(10)00683-5\/abstract"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101214"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06142-4"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.06.006"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-072610-145138"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27778"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12787"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R119000547"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24341"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308331110"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0142"},{"key":"e_1_3_4_123_1","unstructured":"The role of RIPK1-mediated cell death in acute on chronic liver failure. [Internet]. Cell Death Dis. [cited 2024 Jun 6]. Available from: https:\/\/www.nature.com\/articles\/s41419-021-04442-9"},{"key":"e_1_3_4_124_1","unstructured":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7316630\/"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13586"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25485"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.031"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.018"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.11.019"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)91007-9"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.026"},{"key":"e_1_3_4_133_1","unstructured":"Evaluation of CirrhoCare\u00ae \u2013 a digital health solution for home management of individuals with cirrhosis. J Hepatol [Internet]. [cited 2024 Jun 3]. Available from: https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(22)03066-5\/abstract"},{"key":"e_1_3_4_134_1","unstructured":"CirrhoCare\u00ae. [Internet]. [cited 2024 Jun 3]. Available from: https:\/\/cirrhocare.com\/cirrhocare\/"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.2196\/47404"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.004"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i40.14934"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.021"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000671"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.08.041"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.028"},{"key":"e_1_3_4_142_1","unstructured":"The clinical efficacy of double plasma molecular absorption system combined with plasma exchange in the treatment of acute-on-chronic liver failure: a systematic review and meta-analysis. [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8975647\/"},{"key":"e_1_3_4_143_1","unstructured":"Comparison of plasma exchange double plasma molecular adsorption system and their combination in treating acute-on-chronic liver failure. [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7303772\/"},{"key":"e_1_3_4_144_1","unstructured":"Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure. [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11101465\/"},{"key":"e_1_3_4_145_1","unstructured":"Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study. [Internet]. Scientific Reports. [cited 2024 Jun 6]. Available from: https:\/\/www.nature.com\/articles\/s41598-021-89712-4"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14806"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13430"},{"key":"e_1_3_4_148_1","unstructured":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene naltrexone acamprosate baclofen and topiramate. [Internet]. PubMed. [cited 2024 Jun 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28940866\/"},{"key":"e_1_3_4_149_1","unstructured":"Suk KT. Effect of probiotics on gut-liver axis of alcoholic hepatitis. Report No.: NCT02335632. clinicaltrials.gov. 2015 Jan [cited 2024 Jan 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02335632"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2409941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:00:33Z","timestamp":1729076433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2409941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":147,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,9,21]]}},"alternative-id":["10.1080\/14656566.2024.2409941"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2409941","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}